Exercise of Options, Director Dealing and TVR
One Health Group plc announced that CEO Adam Binns exercised 100,035 options at 66.7 pence each, subsequently selling 27,000 shares at 309 pence to cover costs, increasing his total beneficial interest to 87,492 shares, representing 0.6% of the issued share capital. Following the admission of 100,035 new ordinary shares, the total voting rights in the company will be 13,931,868.
Select text to share a quote on X · sign in to keep highlights & notes in your OHGR notes
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through ‘Patient Choice’, announces that on 29 October 2026, Adam Binns, Chief Executive Officer, exercised 100,035 options over ordinary shares of 0.5 pence each in the Company ("Ordinary Shares"). These share options were granted on 17 February 2021 under the Company's approved EMI scheme to employees.
Adam Binns has subsequently sold 27,000 Ordinary Shares to cover the exercise cost and personal tax liabilities arising from the exercise. Consequently, Adam has increased his total beneficial interest in the Company from 14,457 to 87,492 Ordinary Shares Details are set out below:
| Director | Options exercised | Exercise price | Shares sold to satisfy tax liabilities | Sale price | Total shareholding post-exercise and sale | Total shareholding as % of issued share capital |
|---|---|---|---|---|---|---|
| Adam Binns | 100,035 | 66.7p | 27,000 | 309p | 87,492 | 0.6% |
Admission and Total Voting Rights
Pursuant to the exercise of the share options, an application has been made to the London Stock Exchange for admission to trading on AIM of 100,035 new Ordinary Shares (“Admission”). It is expected that Admission will become effective at 8.00 a.m. on 30 October 2026. The new Ordinary Shares will, when issued, be credited as fully paid and rank pari passu in all respects with the existing issued Ordinary Shares.
Following Admission, the total number of ordinary shares and voting rights in the Company will be 13,931,868. The Company does not hold any shares in treasury.
The above figure of 13,931,868 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
Online investor presentation
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Adam Binns |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | One Health Group plc |
| b) | LEI | 984500DC689F5BAD8732 |
| a) | Description of the financial instrument, type of instrument | Options over Ordinary Shares of 0.5 pence each |
| Identification code | GB00BNNT0595 | |
| b) | Nature of the transaction | Exercise of options and partial sale of the resultant shares |
| c) | Price(s) and volumes(s) | As set out in d) below |
| d) | Aggregated information | |
| Exercise of options | ||
| Volume | 100,035 | |
| Price | 66.7p | |
| Sale of Ordinary Shares | ||
| Volume | 27,000 | |
| Price | 309 p | |
| e) | Date of the transaction | 29 October 2026 |
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.